menu
    • menu

    Company profile for Mendus

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Swe...
    Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MendusSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Östermalmstorg 5 114 42 Stockholm
    Telephone
    Telephone
    +46 (0)8 732 8400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mendus.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mendus/?originalSubdomain=se
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mendus to present NK cell program progress at the Innate Killer Summit
    Mendus to present NK cell program progress at the Innate Killer Summit

    19 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/19/2848286/0/en/Mendus-to-present-NK-cell-program-progress-at-the-Innate-Killer-Summit.html

    GLOBENEWSWIRE
    19 Mar 2024
    Share Share
    Mendus shareholders declare their intention to exercise warrants of series TO3
    Mendus shareholders declare their intention to exercise warrants of series TO3

    15 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/15/2846821/0/en/Mendus-major-shareholders-and-members-of-the-Board-of-Directors-and-Management-declare-their-intention-to-exercise-warrants-of-series-TO3.html

    GLOBENEWSWIRE
    15 Mar 2024
    Share Share
    The exercise period for warrants of series TO3 commences today
    The exercise period for warrants of series TO3 commences today

    15 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/15/2846810/0/en/The-exercise-period-for-warrants-of-series-TO3-commences-today.html

    GLOBENEWSWIRE
    15 Mar 2024
    Share Share
    Mendus provides business update and outlook for vididencel program
    Mendus provides business update and outlook for vididencel program

    12 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/12/2844284/0/en/Mendus-provides-business-update-and-outlook-for-vididencel-program.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Mendus to participate in upcoming industry conferences
    Mendus to participate in upcoming industry conferences

    27 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/27/2835659/0/en/Mendus-to-participate-in-upcoming-industry-conferences.html

    GLOBENEWSWIRE
    27 Feb 2024
    Share Share
    Mendus to hold Business Update event on March 12
    Mendus to hold Business Update event on March 12

    23 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/23/2834232/0/en/Mendus-to-hold-Business-Update-event-on-March-12.html

    GLOBENEWSWIRE
    23 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search